Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001938787 | SCV002202359 | uncertain significance | Jeune thoracic dystrophy; Nephronophthisis | 2022-10-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1429151). This variant has not been reported in the literature in individuals affected with TTC21B-related conditions. This variant is present in population databases (rs753608608, gnomAD 0.0009%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 775 of the TTC21B protein (p.Ala775Val). |
Breakthrough Genomics, |
RCV004693992 | SCV005187988 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Fulgent Genetics, |
RCV005023473 | SCV005651258 | uncertain significance | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2024-03-17 | criteria provided, single submitter | clinical testing |